Taboo obsessions and their association with suicidality in obsessive-compulsive disorder.

Comorbidity Heterogeneity Suicidality Symptom dimensions obsessive-Compulsive disorder

Journal

Journal of psychiatric research
ISSN: 1879-1379
Titre abrégé: J Psychiatr Res
Pays: England
ID NLM: 0376331

Informations de publication

Date de publication:
10 2022
Historique:
received: 03 01 2022
revised: 12 06 2022
accepted: 20 07 2022
pubmed: 8 8 2022
medline: 20 9 2022
entrez: 7 8 2022
Statut: ppublish

Résumé

Individuals with obsessive-compulsive disorder (OCD) more often think about, attempt, and die by suicide than individuals from the general population. Sexual and religious obsessions (i.e., taboo obsessions) have been linked to increased risk of suicidality, but it is unclear if they explain additional risk over and above other risk factors. We refined the recently proposed multidimensional hierarchical model of OCD and explored how each symptom dimension in the model was associated with suicidality in a random half (n = 500) of a well-characterized cohort of patients with OCD. Symptom dimensions and other risk factors significantly associated with suicidality were included in a confirmatory multivariable model conducted with the other half of the sample (n = 501). The predictive confirmatory model accounted for 19% of the variance in suicidality. Taboo obsessions, the general OCD factor (i.e., having many different OCD symptoms at the same time), lifetime major depression, and lifetime substance use disorders significantly predicted suicidality in this model. Lifetime major depression explained most unique variance in suicidality (5.6%) followed by taboo obsessions and the general OCD factor (1.9% each). Taboo obsessions explain a small but significant proportion of variance in suicidality and should be considered an independent risk factor for suicidality in patients with OCD.

Identifiants

pubmed: 35933855
pii: S0022-3956(22)00420-4
doi: 10.1016/j.jpsychires.2022.07.044
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

117-122

Informations de copyright

Copyright © 2022 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Auteurs

Matti Cervin (M)

Department of Clinical Sciences Lund, Lund University, Lund, Sweden. Electronic address: matti.cervin@med.lu.se.

Maria Conceição do Rosário (MC)

Department of Psychiatry, Federal University of São Paulo (UNIFESP), Brazil.

Leonardo F Fontenelle (LF)

D'Or Institute for Research and Education (IDOR) and Institute of Psychiatry (IPUB), Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil, and Department of Psychiatry, School of Clinical Sciences, Monash University, Clayton, VIC, Australia.

Ygor A Ferrão (YA)

Department of Clinical Medicine (Neurosciences), Porto Alegre Health Sciences Federal University, Porto Alegre, Brazil.

Marcelo C Batistuzzo (MC)

Department of Psychiatry, Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil & Department of Methods and Techniques in Psychology, Pontifical Catholic University, São Paulo, SP, Brazil.

Albina R Torres (AR)

Department of Neurology, Psychology and Psychiatry, Botucatu Medical School, Universidade Estadual Paulista (Unesp), Brazil.

Rodolfo F Damiano (RF)

Departamento e Instituto de Psiquiatria do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil.

Lorena Fernández de la Cruz (L)

Department of Clinical Neuroscience, Centre for Psychiatry Research, Karolinska Institutet, Stockholm, Sweden & Stockholm Health Care Services, Region Stockholm, Stockholm, Sweden.

Euripedes C Miguel (EC)

Departamento de Psiquiatria da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil.

David Mataix-Cols (D)

Department of Clinical Neuroscience, Centre for Psychiatry Research, Karolinska Institutet, Stockholm, Sweden & Stockholm Health Care Services, Region Stockholm, Stockholm, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH